The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

18 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8.EBI
Washington State University
Evidence for substrate-dependent inhibition profiles for human liver aldehyde oxidase.EBI
Washington State University
Synthesis and evaluation of constrained phosphoramidate inhibitors of prostate-specific membrane antigen.EBI
Washington State University
Near native binding of a fluorescent serotonin conjugate to serotonin type 3 receptors.EBI
Washington State University
Comparative study of the affinity and metabolism of type I and type II binding quinoline carboxamide analogues by cytochrome P450 3A4.EBI
Washington State University
Phosphoramidate derivatives of hydroxysteroids as inhibitors of prostate-specific membrane antigen.EBI
Washington State University
Nucleosides of 1,4-thiazin-3-one and derivatives as tetrahedral intermediate analogues of enzymes in pyrimidine nucleoside metabolism.EBI
Washington State University
Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigen.EBI
Washington State University
A targeted low molecular weight near-infrared fluorescent probe for prostate cancer.EBI
Washington State University
Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.EBI
Washington State University
Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.EBI
Washington State University
High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods.EBI
Washington State University
PSMA-targeted small-molecule drug-conjugates with valine-citrulline and phosphoramidate cleavable linkers.EBI
Washington State University
PSMA-targeted SMART molecules outfitted with SN38.EBI
Washington State University
Charge and substituent effects on affinity and metabolism of benzbromarone-based CYP2C19 inhibitors.EBI
Washington State University
A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.EBI
Washington State University
Identification of the 4-Position of 3-Alkynyl and 3-Heteroaromatic Substituted Pyridine Methanamines as a Key Modification Site Eliciting Increased Potency and Enhanced Selectivity for Cytochrome P-450 2A6 Inhibition.EBI
Washington State University
Novel adenosine-derived inhibitors of 70 kDa heat shock protein, discovered through structure-based design.BDB
Vernalis (R&D)